Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

for
Mild Cognitive Impairment, Chronic Kidney Diseases
Location: Washington D.C. DC, New York NY
Sponsor: Columbia University

Sex: All

Age: 55+

Code: NCT05655325

Recruiting

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

for
Neoplasm Metastasis, Non-Small Cell Lung Cancer
Location: Washington D.C. DC, Fairfax VA, New York NY, Durham NC,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT04886804

Phase 1, Recruiting

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Washington D.C. DC, Baltimore MD, Newark DE,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07154290

Phase 2, Recruiting

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

for
Advanced Renal Cell Carcinoma (aRCC),
Location: Washington D.C. DC, Hershey PA, Chapel Hill NC,
Sponsor: Brian Rini

Sex: All

Age: 18+

Code: NCT07188896

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Washington D.C. DC, Richmond VA, Charlottesville VA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis

for
Lewy Body Dementia Psychosis
Location: Washington D.C. DC, Richmond VA, Columbus OH,
Sponsor: ACADIA Pharmaceuticals Inc.

Sex: All

Age: 55 - 70+

Code: NCT07095465

Phase 3, Recruiting

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

for
Hemorrhage
Location: Washington D.C. DC, Columbus OH, Charlotte NC,
Sponsor: Corza Medical GmbH

Sex: All

Age: 0+

Code: NCT06664775

Phase 3, Recruiting

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

for
Breast Neoplasm Female, Early Detection of Cancer,
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: Female

Age: 18 - 70+

Code: NCT06892275

Recruiting

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

for
Lewy Body Dementia Psychosis
Location: Washington D.C. DC, Richmond VA, Chapel Hill NC,
Sponsor: ACADIA Pharmaceuticals Inc.

Sex: All

Age: 55 - 70+

Code: NCT07029581

Phase 2, Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

for
Agitation, Alzheimer Disease
Location: Washington D.C. DC, Philadelphia PA, Toms River NJ,
Sponsor: Celgene

Sex: All

Age: 55 - 70+

Code: NCT06808984

Phase 2, Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Washington D.C. DC, Bethesda MD, Fairfax VA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06943755

Phase 2, Phase 3, Recruiting

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

for
Familial Adenomatous Polyposis (FAP)
Location: Washington D.C. DC, Baltimore MD, Danville PA,
Sponsor: Rapamycin Holdings Inc.

Sex: All

Age: 18+

Code: NCT06950385

Phase 3, Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

for
Hematologic Disorder, Bleeding Disorder,
Location: Washington D.C. DC, Baltimore MD, Wilmington DE,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 0+

Code: NCT04398628

Recruiting

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

for
Solid Tumors
Location: Washington D.C. DC, Fairfax VA, Philadelphia PA,
Sponsor: ORIC Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05315700

Phase 1, Phase 2, Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

for
Locoregional Recurrence,
Location: Washington D.C. DC, Hershey PA, Richmond VA,
Sponsor: Oana Danciu

Sex: All

Age: 18+

Code: NCT05467891

Phase 2, Recruiting

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

for
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
Location: Washington D.C. DC, Fairfax VA, Louisville KY,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07407933

Phase 1, Phase 2, Recruiting

Nilotinib in Huntington's Disease

for
Huntington Disease
Location: Washington DC
Sponsor: Georgetown University

Sex: All

Age: 25 - 70+

Code: NCT03764215

Phase 1, Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

for
Non Small Cell Lung Cancer, Esophageal Cancer,
Location: Washington D.C. DC, Fairfax VA, New York NY,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT05983432

Phase 1, Recruiting

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Washington D.C. DC, Fairfax VA, Pittsburgh PA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06162221

Phase 1, Phase 2, Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumor
Location: Washington D.C. DC, Fairfax VA, East Brunswick NJ,
Sponsor: Pliant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06270706

Phase 1, Recruiting